Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJohnson & Johnson Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 12 | $2.41 | $2.86 | $2.68 |
| Q2 2026 | 11 | $2.70 | $2.92 | $2.85 |
| Q3 2026 | 5 | $2.39 | $3.02 | $2.85 |
| Q4 2026 | 5 | $2.92 | $3.19 | $3.00 |
| Q1 2027 | 1 | $2.86 | $2.92 | $2.89 |
| Q2 2027 | 1 | $3.08 | $3.15 | $3.12 |
| Q3 2027 | 1 | $3.24 | $3.32 | $3.28 |
| Q4 2027 | 1 | $3.31 | $3.39 | $3.35 |
| Q1 2028 | 2 | $3.05 | $3.12 | $3.09 |
| Q2 2028 | 2 | $3.36 | $3.43 | $3.40 |
| Q3 2028 | 2 | $3.54 | $3.62 | $3.59 |
| Q4 2028 | 2 | $3.47 | $3.55 | $3.51 |
Johnson & Johnson Earnings Date And Information
Johnson & Johnson last posted its earnings results on Wednesday, July 15th, 2026. The company reported $2.9 earnings per share for the quarter, topping analysts' consensus estimates of $2.84 by $0.06. The company had revenue of 25.31 B for the quarter and had revenue of 94.19 B for the year. Johnson & Johnson has generated $11 earnings per share over the last year ($11.03 diluted earnings per share) and currently has a price-to-earnings ratio of 31.21. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Johnson & Johnson Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/23/2026 | Q2 2026 | N/A | $2.27 | N/A | $25.06 B | $25.31 B |
| 04/22/2026 | Q1 2026 | N/A | $2.14 | N/A | $23.61 B | $24.06 B |
| 02/11/2026 | Q4 2025 | N/A | $2.10 | N/A | $24.15 B | $24.56 B |
| 10/22/2025 | Q3 2025 | N/A | $2.14 | N/A | $23.76 B | $23.99 B |
| 07/24/2025 | Q2 2025 | N/A | $2.29 | N/A | $22.85 B | $23.74 B |
| 04/23/2025 | Q1 2025 | N/A | $4.57 | N/A | $21.56 B | $21.89 B |
| 02/13/2025 | Q4 2024 | N/A | $1.43 | N/A | $22.43 B | $22.52 B |
| 10/23/2024 | Q3 2024 | N/A | $1.12 | N/A | $22.17 B | $22.47 B |
| 07/25/2024 | Q2 2024 | N/A | $1.95 | N/A | $22.33 B | $22.45 B |
| 05/01/2024 | Q1 2024 | N/A | $1.35 | N/A | $21.40 B | $21.38 B |
| 02/16/2024 | Q4 2023 | N/A | $1.68 | N/A | $21.02 B | $21.40 B |
| 10/27/2023 | Q3 2023 | N/A | $10.32 | N/A | $21.04 B | $21.35 B |
| 07/31/2023 | Q2 2023 | N/A | $1.98 | N/A | $24.63 B | $21.52 B |
| 04/28/2023 | Q1 2023 | N/A | -$0.03 | N/A | $23.60 B | $20.89 B |
| 02/16/2023 | Q4 2022 | N/A | $1.35 | N/A | $23.88 B | $23.71 B |
| 10/27/2022 | Q3 2022 | N/A | $1.70 | N/A | $23.36 B | $20.00 B |
| 07/29/2022 | Q2 2022 | N/A | $1.83 | N/A | $23.77 B | $24.02 B |
| 04/29/2022 | Q1 2022 | N/A | $1.96 | N/A | $23.62 B | $23.43 B |
| 02/17/2022 | Q4 2021 | N/A | $1.80 | N/A | $25.28 B | $24.80 B |
| 10/29/2021 | Q3 2021 | N/A | $1.39 | N/A | $23.64 B | $23.34 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Johnson & Johnson Earnings: FAQ's
In the previous quarter, Johnson & Johnson (:JNJ) reported $2.9 earnings per share (EPS) to beat the analysts' consensus estimate of $2.84 by $0.06.
The conference call for Johnson & Johnson's latest earnings report can be listened to online.
The conference call transcript for Johnson & Johnson's latest earnings report can be read online.
Johnson & Johnson (:JNJ) has a recorded annual revenue of $94.19 B.
Johnson & Johnson (:JNJ) has a recorded net income of $26.80 B.Johnson & Johnson has generated $11.03 earnings per share over the last four quarters.
Johnson & Johnson (:JNJ) has a price-to-earnings ratio of 31.21 and price/earnings-to-growth ratio is -3.86.